AC Immune
Series D+AC Immune raised €40M in a Series D+ round in May 2016. The company is based in Lausanne, Switzerland. Data as of Nov 2026.
Amount raised
€40M
€39,545,455
Native amount
39,545,455 EUR
Stage
Series D+
series e
Investors
0
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €40M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0 namedNo investors disclosed for this round.
Date
May 2016
Round type
series e
Amount (EUR)
€40M